Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Episurf Major Shareholding Notification 2019

Jan 17, 2019

3157_iss_2019-01-17_9e438043-5dd0-49b0-9ad9-f667687434a0.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Episurf Medical AB

Holder

Serendipity Group AB

Instrument

Instrument A-shares
Before the transaction
Shares 4,601,519
Voting rights 13,804,557
Transaction
Reason for major shareholding notification Sell
Date 14/01/2019
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 0
Directly held voting rights 0
Indirectly held voting rights 0
Percentage
Directly held shares 0 %
Directly held voting rights 0 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares

Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3

  • Physically settled
  • Cash settled

Total

Group total holdings

Voting rights 0

Percentage of voting rights 0 Notes (other relevant informations according to law)

Flaggningen görs med anledning av en omstrukturering av ägandet av Serendipity Ixora AB ("Ixora"), som äger aktier i Episurf Medical AB ("Episurf"). Serendipity Group AB ("Group") har tidigare varit moderbolag till Ixora och därmed tillsammans med Ixora varit skyldig att rapportera transaktioner i Episurf-aktien. Den 14 januari 2019 delade Group ut de aktier bolaget ägde i Ixora till sina aktieägare och därmed föreligger inte längre något moderbolagsförhållande mellan Group (eller någon annan fysisk eller juridisk person) och Ixora. Group har därmed inget indirekt ägande i Episurf. Ixora har dock samma ägande i Episurf som tidigare.

Published

17/01/2019 10:55

Contact Name Saeid Esmaeilzadeh

Phone 0707187061 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25